Locally-made drugs increasing share of Russian pharma market

Progress and growth of the Russian pharmaceutical industry were the subject of  press conference yesterday, under the theme: “Initiatives to support Russian manufacturers, myths and reality.” The conference was attending by leading pharma and pharmacy organization, along with drugmakers.

Opening the press conference, Nelli Ignatieva, executive director of the Russian Association of Pharmacy Chains (RAPC), noted that pharmacy organizations work in close relationship with pharmaceutical manufacturers. “Today our pharmaceutical market is at the development stage. The trend, that medicines are made “on the knees,” should be left in the past. Now these are high-quality products that are not inferior to their foreign analogs,” she stated.

Viktor Dmitriev, director general of the Association the Russian pharmaceutical producers (ARPM), continuing the topic, emphasized that in recent years, the domestic pharmaceutical market has shown significant growth. “In many respects this is due to the adopted strategy of “Pharma 2020.” The market has passed for 1 trillion roubles [~$15 billion]. It is gratifying to note that Russian or, as it is said now, locally produced drugs, account for 80% of the VED list. ”